Stereochemistry | ACHIRAL |
Molecular Formula | C4H7N3O |
Molecular Weight | 113.1179 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CC(=O)N=C1N
InChI
InChIKey=DDRJAANPRJIHGJ-UHFFFAOYSA-N
InChI=1S/C4H7N3O/c1-7-2-3(8)6-4(7)5/h2H2,1H3,(H2,5,6,8)
HIDE SMILES / InChI
CNS Activity
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|
Title | Date | PubMed |
---|---|---|
Diabetic uraemia and haemodialytic treatments. | 2001 |
|
Clinical research in peritoneal dialysis. | 2001 |
|
Prevention of kidney ischemia/reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. | 2001 Apr 13 |
|
Brain proton magnetic resonance spectroscopy and imaging in children exposed to cocaine in utero. | 2001 Feb |
|
Human SA gene Pst1 polymorphism and chronic renal failure: results of the family-based study. | 2001 Feb |
Showing 1 to 5 of 34 entries
Patents
Sample Use Guides
Small amounts of creatinine are normally administered with food. In the study oral administration of up to 7g of creatinine does not lead to elevation of creatinine levels in the blood.
Route of Administration:
Oral
The blood level of creatinine is routinely measured by measurement devices. Method principles are based on a cascade of enzymatic reactions, followed by either photometric or electrochemical detection. Preferred sample types vary from whole blood to serum/plasma or both. Sample volumes range from 1 to 30 μL generally. A normal result for creatinine blood test is 0.7 to 1.3 mg/dL for men and 0.6 to 1.1 mg/dL for women.
Code System | Code | Type | Description |
---|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
200-466-7 | PRIMARY | |||
|
SUB33051 | PRIMARY | |||
|
CREATININE | PRIMARY | |||
|
CHEMBL65567 | PRIMARY | |||
|
16737 | PRIMARY |
Showing 1 to 5 of 18 entries
ACTIVE MOIETY
PARENT (METABOLITE)
PARENT (METABOLITE)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)